Does the neurotensin receptor-1 pathway contribute to human ductal breast cancer progression?
these data support the activation of neurotensinergic deleterious pathways in breast cancer progression.
Our data showed a heterogeneous electroclinical phenotype with generalized and partial epilepsy, presenting distinct degrees of severity and refractoriness.